NZOZ Specjalistyczny Osrodek Dermatologiczny DERMAL s.c.
About NZOZ Specjalistyczny Osrodek Dermatologiczny DERMAL s.c.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at NZOZ Specjalistyczny Osrodek Dermatologiczny DERMAL s.c.
During the past decade, NZOZ Specjalistyczny Osrodek Dermatologiczny DERMAL s.c. conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on
average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life
2014-09-01
2016-05-01
Completed
103
Construal Level as a Novel Pathway for Affect Regulation and Cancer Control
2021-10-11
2026-02-15
Recruiting
213
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at NZOZ Specjalistyczny Osrodek Dermatologiczny DERMAL s.c.
According to Clinical.Site data, the most researched conditions in "NZOZ Specjalistyczny Osrodek Dermatologiczny DERMAL s.c." are
"Atopic Dermatitis" (4 trials), "Dermatitis, Atopic" (3 trials), "Skin Diseases" (3 trials), "Dermatitis" (1 trials) and "Eczema" (1 trials). Many other conditions were trialed in "NZOZ Specjalistyczny Osrodek Dermatologiczny DERMAL s.c." in a lesser frequency.
Clinical Trials Intervention Types at NZOZ Specjalistyczny Osrodek Dermatologiczny DERMAL s.c.
Most popular intervention types in "NZOZ Specjalistyczny Osrodek Dermatologiczny DERMAL s.c." are "Drug" (8 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Abrocitinib 200 mg" (2 trials), "Orismilast modified release tablets" (2 trials), "PF-04965842 100 mg" (2 trials) and "PF-04965842 200 mg" (2 trials). Other intervention names were less common.
Clinical Trials Genders at NZOZ Specjalistyczny Osrodek Dermatologiczny DERMAL s.c.
The vast majority of trials in "NZOZ Specjalistyczny Osrodek Dermatologiczny DERMAL s.c." are
8 trials for "All" genders.
Clinical Trials Status at NZOZ Specjalistyczny Osrodek Dermatologiczny DERMAL s.c.
Currently, there are NaN active trials in "NZOZ Specjalistyczny Osrodek Dermatologiczny DERMAL s.c.".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in NZOZ Specjalistyczny Osrodek Dermatologiczny DERMAL s.c.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in NZOZ Specjalistyczny Osrodek Dermatologiczny DERMAL s.c., 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".